Comprehensive Biomarker Assay Lab Services on Advanced Bioanalytical Platforms!

Biomarkers are measurable indicators of biological processes, conditions, or diseases. They are essential for diagnosing diseases, monitoring disease progression, and assessing the effectiveness of treatments.

Biomarker testing and analysis involve using various methods to measure biomarkers in biological samples. This analysis helps identify specific biomarkers related to diseases, drug effects, or therapeutic outcomes.

We offer a wide range of biomarker testing services, including multiplex assays, pharmacodynamic biomarker assays, and gene expression analysis using advanced platforms like ELISA, MSD, Luminex, and LC-MS.

Our testing process includes sample collection, biomarker assay development, validation, and quantification using platforms such as qPCR, flow cytometry, and Western blot. We tailor each assay to the needs of the study, ensuring accurate and reliable results.

We utilize a variety of cutting-edge platforms for biomarker research, including ELISA, Luminex, MSD, qPCR, dPCR, and LC-MS. These technologies allow for highly sensitive and multiplexed analysis, ensuring comprehensive biomarker profiling.

Biomarker assays are crucial during drug development for target identification, dose optimization, patient stratification, and monitoring therapeutic efficacy. They provide essential biomarker data on how a drug interacts with its target and the biological system.

Our biomarker discovery services focus on identifying novel biomarkers through genomic, proteomic, and metabolomic profiling. These services support early-phase research and help identify potential biomarkers for disease diagnosis and therapeutic response.

We provide comprehensive biomarker development services, including assay design, optimization, and qualification. Our goal is to create robust, reproducible assays that can be used for clinical trials or therapeutic monitoring.

Our biomarker validation services ensure that biomarkers perform reliably in real-world scenarios. This includes testing biomarker specificity, sensitivity, and reproducibility across diverse sample types.

Biomarker qualification services ensure that a biomarker is fit for its intended use in clinical trials or as a diagnostic tool. This process includes evaluating assay performance, accuracy, and clinical relevance.

Biomarker testing accelerates drug development by providing insights into drug efficacy, safety profiles, and optimal patient populations. This leads to more informed decision-making, reducing risks and improving the chances of regulatory approval.